Endothelin A receptor blockade improves endothelium-dependent relaxation in obese woman
Language English Country Czech Republic Media print
Document type Journal Article
PubMed
29947537
DOI
10.33549/physiolres.933813
PII: 933813
Knihovny.cz E-resources
- MeSH
- Endothelin A Receptor Antagonists pharmacology therapeutic use MeSH
- Endothelium, Vascular drug effects metabolism MeSH
- Peptides, Cyclic pharmacology therapeutic use MeSH
- Hypertension drug therapy metabolism surgery MeSH
- Middle Aged MeSH
- Humans MeSH
- Obesity drug therapy metabolism surgery MeSH
- Organ Culture Techniques MeSH
- Receptor, Endothelin A physiology MeSH
- Adipose Tissue blood supply drug effects metabolism MeSH
- Vasodilation drug effects physiology MeSH
- Dose-Response Relationship, Drug MeSH
- Gastric Bypass trends MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Endothelin A Receptor Antagonists MeSH
- cyclo(Trp-Asp-Pro-Val-Leu) MeSH Browser
- Peptides, Cyclic MeSH
- Receptor, Endothelin A MeSH
Hypertension in obesity is associated with increased insulin resistance, vascular mass and body mass index (BMI). The purpose of the study was to visualize endothelin-1 (ET-1) mediated constriction in arteries isolated from subcutaneous adipose tissue from obese hypertensive women previously operated by gastric bypass. Functional studies were conducted in a microvascular myograph. Expressed as percentage of contraction elicited by 124 mM KCl concentration-response curves for ET-1 were shifted leftward in arteries from obese hypertensive patients compared to healthy normotensive subjects. The vasodilator response to the ET-1 antagonist BQ123 (1 microM) was significantly higher in arteries from obese hypertensive patients (p<0.001). BQ123 induced relaxation was inhibited by NO synthase inhibitor L-NAME (0.1 nM). Preincubation with BQ123 enhanced the relaxation induced by acetylcholine (ACh; 0.1 nM - 0.1 mM) (p<0.001), but not that induced by NO donor sodium nitroprusside (SNP; 0.1 nM - 0.1 mM), in arteries from obese hypertensive patients. The present study show that hypertension yet prevail after gastric bypass surgery and the ET(A) receptor antagonist BQ123 may be a useful tool in reducing blood pressure in obese hypertensive patients.
References provided by Crossref.org